Annual Mood Disorder Symposium April 5
The fourth annual
, presented by the
, is scheduled for Saturday, April 5, at the Conference Center at Drake, 151 W. Galbraith Road. The theme is, "Novel Treatment Approaches for Depression.
Registration is at 7 a.m., with faculty presentations beginning at 8 following a welcome and overview by Stephen Strakowski, MD, the Dr. Stanley and Mickey Kaplan Professor and Chair of Psychiatry and Behavioral Neuroscience.
In addition to novel treatment options, topics will include new non-pharmacologic strategies for treating depression and the impact of neurodevelopmental changes on depression treatment. Course co-directors are Cal Adler, MD, Stephen Benoit, PhD, and Melissa DelBello, MD.
Continuing education credit is available. Fees are $75 in advance for physicians ($90 at the door); $75 for nurses, $50 for mental health professionals, $25 for residents and students (UC psychiatry residents free).
For more information, contact Sonya Kirkland at 513-558-4866 or
.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.